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Abstract
Background: Glucocorticoids are potent anti-inflammatory agents used for the
treatment of diseases such as rheumatoid arthritis, asthma, inflammatory bowel
disease and psoriasis. Unfortunately, usage is limited because of metabolic side-
effects, e.g. insulin resistance, glucose intolerance and diabetes. To gain more insight
into the mechanisms behind glucocorticoid induced insulin resistance, it is important
to understand which genes play a role in the development of insulin resistance and
which genes are affected by glucocorticoids.
Medline abstracts contain many studies about insulin resistance and the molecular
effects of glucocorticoids and thus are a good resource to study these effects.
Results: We developed CoPubGene a method to automatically identify gene-disease
associations in Medline abstracts. We used this method to create a literature network
of genes related to insulin resistance and to evaluate the importance of the genes in
this network for glucocorticoid induced metabolic side effects and anti-inflammatory
processes.
With this approach we found several genes that already are considered markers of
GC induced IR, such as phosphoenolpyruvate carboxykinase (PCK) and glucose-6-
phosphatase, catalytic subunit (G6PC). In addition, we found genes involved in steroid
synthesis that have not yet been recognized as mediators of GC induced IR.
Conclusions: With this approach we are able to construct a robust informative
literature network of insulin resistance related genes that gave new insights to better
understand the mechanisms behind GC induced IR. The method has been set up in
a generic way so it can be applied to a wide variety of disease networks.
Keywords: Literature mining, Insulin resistance, Glucocorticoids, Gene networks
Background
Glucocorticoids (GCs) are often prescribed for the treatment of inflammatory diseases
such as rheumatoid arthritis, asthma, inflammatory bowel disease and psoriasis [1-3].
Despite their excellent efficacy, usage is limited because of side-effects such as insulin
resistance, glucose intolerance, diabetes, central adiposity, dyslipidemia, skeletal muscle
wasting and osteoporosis [4-8].
GCs bind to the glucocorticoid receptor (GR), which then dimerizes and translocates
to the nucleus where it influences gene transcription. Positive regulation of genes
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(transactivation) is mainly mediated by direct binding of the GR-GC complex to gluco-
corticoid response elements located in the regulatory region of a target gene. The
GR-GC complex may also bind to negative glucocorticoid response elements, which
leads to a negative regulation of genes (transrepression). It is believed that transrepres-
sion, in which proinflammatory genes are downregulated, is mainly responsible for the
efficacy of GCs as anti-inflammatory drugs [5,7], while transactivation might be respon-
sible for the GC-induced adverse effects [9].
An important side effect is the development of insulin resistance (IR), because it is
the onset of many metabolic diseases and conditions such as obesity, diabetes mellitus
and hypertension. IR is a physiological condition in which a given concentration of in-
sulin produces a less-than-expected biological effect. These biological effects are differ-
ent depending on the tissue in which they occur. For instance, under IR conditions, fat
and muscle cells fail to adequately respond to circulating insulin, which results in
reduced glucose uptake, and subsequently higher glucose levels in blood [10,11]. In
liver cells the IR- effects can be seen in reduced glycogen synthesis and storage, and a
failure to suppress glucose production and release into the blood.
One way by which GCs induce IR is by inhibition of the recruitment of GLUT4 glu-
cose transporter, which results in reduced insulin-stimulated glucose transport in skel-
etal muscle [12]. However, not all mechanisms involved in GC-induced side effects are
not completely understood. To gain more insight into mechanisms behind GC induced
IR, it is important to understand which genes play a role in the development of insulin
resistance and which genes are affected by GCs.
It has been widely recognized that a system approach in which networks of genes in
their functional context are studied, contributes to a better understanding of the
mechanisms and pathways related to the disease and the drug effects [13-17]. To study
a gene network related to a disease such as IR, a list of disease related genes as well as
a notion of the interactions between these genes is needed.
Literature databases such as Medline contain many studies about IR and the molecu-
lar effects of synthetic glucocorticoids and thus are a good resource that can be used to
create and study disease related gene networks.
The retrieval of relevant gene-disease associations out of the millions of abstracts in
Medline is very labor intensive and thus a text mining system is needed to this in an
automated fashion.
In previous work we reported about CoPub [18-20], a publicly available text mining
system, which has successfully been used for the analysis of microarray data and in tox-
icogenomics studies [21-26]. CoPub calculates keyword co-occurrences in titles and
abstracts from the entire Medline database, using thesauri for genes, diseases, drugs
and pathways. We used this technology to develop CoPubGene, a rapid gene – disease
network building tool. To evaluate the importance of genes in these networks we
implemented a method to score the importance of genes in biological processes of
interest by incorporating their functional neighborhood.
We used CoPubGene to create a network of genes related to insulin resistance and to
evaluate the importance of the genes in this network for glucocorticoid induced meta-
bolic side effects and anti-inflammatory processes.
By using this method, we identified several genes that already are considered markers
of GC induced IR, such as phosphoenolpyruvate carboxykinase (PCK) and glucose-6-
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phosphatase, catalytic subunit (G6PC) [27,28]. Even more importantly, we were able to
identify genes involved in steroid synthesis that have not yet been recognized as media-
tors of GC induced IR.
Methods
CoPubGene
We constructed CoPubGene as a SOAP based web service (Table 1). This CoPub Web
Service WSDL is created in Eclipse using the so-called Document Literal Wrapped
style. The web service provider code is written in Perl using the SOAP::WSDL module
and is available via the CoPub portal http://www.copub.org.
Retrieval of Gene-Disease associations
To create disease related gene networks, we used CoPubGene to retrieve gene-disease
and gene-gene associations from Medline abstracts. Disease terms which had signifi-
cant gene associations based on the R-scaled score (rs > 35) and literature count (lc > 5)
in Medline abstracts, were extracted from the CoPub thesaurus.
Table 1 List of available operations of the CoPub Web Service
Name Operation name Input Output Description
Get genes Get_genes Gene
name,
gene
identifier
Biological identifier
(s), with gene
specific
information
Each gene in CoPub belongs to an
internal identifier (biological identifier).
Get_genes converts the input gene to
such a Biological identifier. This
biological identifier serves as an input
for subsequent operations.
Get
Keywords
Get_keywords Keyword Biological identifier
(s), with keyword
specific
information
Retrieves for a set of keywords, the
Biological identifiers to which these
keywords belong in CoPub. These
biological identifiers serve as an input
for subsequent operations.
Get
references
Get_references Biological
identifier
(s)
Literature
references
Given a Biological identifier, retrieves
all abstracts in which the term occurs.
Get
literature
neighbours
Get_literature_neighbours Biological
identifier
(s)
Literature
neighbors
Given a Biological identifier, retrieves a
list of keywords which are mentioned
in the literature together with the
input term.
Get
enriched
keywords
Get_enriched_keywords List of
gene
identifiers
List of enriched
keywords
For a list of genes, this operation
calculates a keyword
overrepresentation.
Get
literature
network
Get_literature_network Biological
identifier
(s)
SVG / Cytoscape
network
For a set of genes, the operation
creates a network of genes.
Get
categories
Get_Categories - List of categories Returns a list of categories of terms in
CoPub
Get chips Get_chips - List of microarrays Returns a list of available Affymetrix
chip names in CoPub.
Version Version - Version of code
and literature
Returns the version of the code and
literature.
Selftest Selftest - Diagnostic
information
-
Biological identifiers are used by CoPub to identify biological concepts in the system. Each biological concept has a
unique identifier.
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Disease clustering
Disease clustering was done in R (http://www.r-project.org) using the pvclust R package
with “complete” setting for hierarchical clustering, based on correlation distance of
R-scaled scores between genes and diseases, with 100 bootstrap replications. The hier-
archical cluster was visualized using Denroscope [29]. Additional gene set enrichment
analysis against the GENETIC_ASSOCIATION_DB_DISEASE was done with the anno-
tation server DAVID [30,31].
Creation of IR gene network
CoPubGene was used to create a set of genes related to IR, by searching for associa-
tions between genes and IR in Medline abstracts using default values (rs > 30 and lc >
5). Subsequently the IR-gene network was created by connecting genes that had signifi-
cant co-occurrences with each other.
Keyword enrichment analysis of IR related genes
Keyword enrichment analysis on the list of IR related genes was done against disease
and drug terms from the CoPub database. Threshold values were chosen using default
values.
Analysis of the IR gene network and calculation of neighbor score for genes
The IR gene network was analyzed by mapping specific occurrences of the IR related
genes with ‘inflammation’ and ‘dexamethasone’ in Medline abstracts onto the network.
For the evaluation of the involvement of a gene, calculation of the literature score for a
given gene and a given disease term, also the effects of dexamethasone and inflamma-
tion on the connecting genes are included. The literature score for gene g with term d
is calculated in the following way:
Literaturescoreg ¼ g1þ Ns2 ; Ns ¼
rg2  g2ð Þ þ rg3  g3ð Þ þ :: rgn  gnð Þ
rg2þ rg3þ ::rgn
In which g1 is the R-scaled score of gene g with term d, and Ns is the literature score
of its neighboring genes with term d. This latter score Ns is calculated using the R-
scaled score of each neighboring gene of gene g with term d (g2, g3,..,gn) relative to its
relation (R-scaled score) with gene g (rg2, rg3,..,rgn).
Results
We developed CoPubGene by creating a number of web service operations that can be used
to construct networks of genes based on their co-occurrences in Medline abstracts. These
web service operations can be combined to answer a variety of biological questions (Table 1).
For example, the question “to what biological processes is this gene related?” can be
answered by running the “get genes” and “get literature neighbours” functions. Using subse-
quently the “get references” function will return all the relevant pubmed entries in which
the gene and keywords co-occur. By applying the “get keywords” and “get literature neigh-
bours” functions one can retrieve all disease terms that are linked to a given drug term in
the Medline abstract, or vice versa, retrieve all drug terms that are linked to a given disease
term in abstracts. The networks that are created can be written to Cytoscape for down-
stream applications and visualizations. Also more advanced questions such as the
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construction of disease related gene networks, and subsequent calculation of keyword en-
richment in this network can be addressed in an automatic way. In Table 1 the available
web service operations are shown.
Retrieval of gene-disease associations
Our aim was to get insight into the pathways and genes that are involved in insulin re-
sistance, and the effect of glucocorticoids on this network. As a first step we created a
list of genes associated with insulin resistance using CoPubGene. This yielded a list of
384 genes each of them connected to IR with an R scaled score (in Additional file 1:
Table S2A the top scoring genes with IR are shown, the full list is available in
Additional file 2: Table S2). To evaluate the quality of this list and to investigate
whether this gene list is unique for IR or whether this list contains a large number of
genes that are associated with multiple diseases we constructed a gene association list
for all diseases in the disease thesaurus of CoPub, using similar parameter settings as
used for construction of the IR gene list. This yielded a list of disease profiles with for
each disease, a number of genes connected to that disease with an R scaled score.
(Additional file 1: Table S2 shows the results for a few selected diseases, the full table is
available in Additional file 2: Table S3).
These disease profiles were clustered using hierarchical clustering with multiscale
bootstrap resampling, grouping together disease terms which have a similar profile, i.e.
co-occur with the same genes (Figure 1; See Additional file 3: Figure S2 for the cluster
with all bootstrap values). It appeared that a number of clusters of similar disease terms
i.e. disease terms for which it is known that they have similar symptoms or have a simi-
lar mode of action, could be identified. For instance cancer related terms, such as ‘can-
cer of breast’, ‘cancer of prostate’ and ‘colon cancer’ are clustered together and
inflammatory related disease terms such as ‘psoriasis’, ‘inflammatory bowel disease’ and
‘asthma’ are clustered together. These clusters also have high unbiased (AU) bootstrap
values, indicating strong evidence for these clusters. To further confirm that the found
gene-disease associations by CoPub are indeed biologically relevant, for each sub-
cluster in Figure 1, we collected the union of all genes for that sub-cluster, and used
these genes to perform a functional annotation analysis against the genetic association
disease database using DAVID. The results of this analysis indicated that indeed similar
disease terms to CoPub were found by DAVID (for the results of this analysis see Add-
itional file 4). These analyses showed that with CoPubGene we are able to construct a
relevant list of specific IR related genes that can be used for further analysis and that
CoPubGene can be used to create a variety of disease related genes lists.
Network of insulin resistance related genes
To create the IR gene network, we used the 384 genes from the IR gene list and con-
nected the genes based on their co-occurrences with each other in Medline abstracts.
The resulting network is shown in Figure 2A. We found that 381 genes of the IR gene
list were connected to at least one other gene. We identified a number of hubs such as
peroxisome proliferator-activated receptor gamma (PPARG), insulin receptor substrate 1
(IRS1), v-akt murine thymoma viral oncogene homolog 1 (AKT1), insulin receptor
(INSR), solute carrier family 2 (facilitated glucose transporter), member 4 (SLC2A4) and
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insulin (INS) which were connected to more than 100 other genes. The resulting net-
work is a scale free network, as indicated by the distribution of connectivity that fol-
lows a power law distribution which is indicative for a scale free network (Additional
file 5: Figure S1) [32]. Although the above network has the characteristics of a bio-
logical network, and contains the expected genes as central hubs, without additional
annotations this network representation is still largely uninformative and contains too
little substructure to draw biological conclusions.
Annotation of the network with drugs and diseases terms
As a first step towards annotating the network and identification of sub networks with
a shared biological function, we investigated which drugs and diseases in the literature
are specifically linked to this network using a keyword enrichment analysis on the list
of IR related genes (For details about the enrichment method see Table 1). This enrich-
ment yielded a number of drugs that are known drugs for the treatment of diabetes
such as ‘rosiglitazone’, ‘metformin’ , ‘pioglitazone’, and also ‘glucagon’ and ‘insulin’ which
are frequently used for the treatment of hypoglycemia and hypoinsulinemia (Table 2A.
For the full list see Additional file 2: Table S4A). Notably, among these top scoring
drugs we found dexamethasone, a well known synthetic glucocorticoid. High scoring
genes with dexamethasone are for instance CEBPA, SERPINA6, PCK2 and GPD1 (for a
Figure 1 Hierarchical cluster of disease terms from the CoPub database. The top 80 disease terms
with the most gene associations are shown. Disease terms are clustered together based on having the
same gene associations. Red numbers at the nodes represent approximately unbiased bootstrap values (%).
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full list of genes per enriched drug term, see Additional file 2: Table S4A.2), which also
have been mentioned in the development of several metabolic diseases [33-37].
There are several top scoring over-represented terms that are related to metabolic dis-
eases, e.g. ‘diabetes mellitus’, ‘obesity’, ‘diabetes mellitus, type 2’ and ‘hyperinsulinemia’
(Table 2B). The fact that these terms are high scoring is expected since we constructed the
gene network based on the keyword insulin resistance. However we also found diseases that
share a common origin with insulin resistance such as cardiovascular disease (Table 2B).
The most interesting high scoring term for our particular research question was the non-
metabolic term ‘inflammation’, which was represented in the network by genes such as IL6,
IL18, IL1RA, SOCS1, SOCS3, CCL2 and CCR2. Several of these genes have been mentioned
in studies to be involved in the development of metabolic diseases. For instance, elevated
levels of IL6 in subjects with obesity and diabetes showed an association between insulin re-
sistance and IL6 [38]. Studies in mice showed that CCR2 deficiency or antagonism of this
receptor resulted in attenuation of systemic insulin resistance and development of obesity,
hence suggesting a modulating role of CCR2 in this [39,40].
These results show that even with an unbiased data driven construction of a gene net-
work, the relation between IR, dexamethasone and inflammation is discovered based on the
genes that play a role in these effects. We subsequently highlighted the genes in the IR net-
work that are related to inflammation and dexamethasone (Figure 2).
Genes linked to inflammation and glucocorticoids in the context of insulin resistance
From a drug development perspective it is interesting to separate the desired effect of
GCs on inflammatory processes from the undesired effect on metabolic processes. To
Figure 2 Literature network of insulin resistance related genes (A). Genes, represented by nodes are
linked, based on co-occurrences in Medline abstracts. The thickness of the edge indicates the strength of
the link between two genes (R-scaled score). Genes in blue have a co-occurrence with dexamethasone in
Medline abstracts (R-scaled score). The strength of the link with dexamethasone is given by the color
shading, ranging from no link (white) to a strong link (dark blue). The strength of the link with inflammation
(R-scaled score) is given by the size of the node of the gene, ranging from no link (normal size of the node)
to a strong link with inflammation (large size of the node). Sub-network for gene PPARG (B). Sub-network of
Cytochrome P450s (C).
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rank each gene with respect to the relation with GC and inflammation, we calculated
for each gene a literature score with dexamethasone and inflammation. Subsequently
we focused on genes that score low on inflammation and high on dexamethasone (Fig-
ure 3). These genes are thought to be more exclusively related to GC induced IR. For
these genes we calculated a literature neighbor score as well, by also including the rela-
tions of dexamethasone and inflammation with genes to which the gene is connected
in the network. In Figure 3 it is shown that many genes which are not directly con-
nected to inflammation (grey dots) are definitely influenced by inflammation via their
connecting genes (black dots).
Table 2 Over-represented drug and disease terms (P-value < 0.05)
A
Term Number of genes
insulin 358
dexamethasone 195
nitric oxide 193
estrogen 169
adenosine 151
estradiol 145
rosiglitazone 125
actinomycin 124
actinomycin d 121
glucagon 120
thrombin 108
progesterone 97
trypsin 86
nicotinamide 85
metformin 84
pioglitazone 82
B
Term Number of genes
insulin resistance 381
obesity 263
inflammation 219
diabetes mellitus 190
cardiovascular disease 181
Diabetes mellitus,type 2 173
Oxygen deficiency 164
fibrosis 138
hyperinsulinemia 137
Cancer of breast 131
Adiposity 130
cancer 128
starvation 120
The top scoring drug terms in the IR network from the CoPub database (A). Top scoring disease terms from the CoPub
database in the IR network (B).
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The majority of the genes in Figure 3 are directly involved in important metabolic
processes such as gluconeogenesis (PCK2, G6PC, PC and GCG), glycolysis (GCK,
GCG), glucose uptake, lipid metabolism (ACACA, CHPT1, GPD1) and carbohydrate
metabolism (GPD1). Other ones are directly involved in insulin signaling (GIP, IGF2,
IPF1, IAPP).
Sex steroid physiology in relation to insulin resistance
Interestingly in Figure 3 we also see three cytochrome P450s, i.e. CYP17A1, CYP19A1
and CYP21A2, which are key regulator enzymes in the steroid synthesis (Figure 4). The
sub-network in Figure 2C shows the three cytocromes P450s and their direct gene
neighbors. Analysis of this sub-network showed that many of the genes in the network
are mentioned in studies from women suffering of the Polycystic ovary syndrome
(PCOS), in which there is an imbalance of a woman's female sex hormones. PCOS is
characterized by insulin resistance, possibly because of hyperandrogenism and low
levels of SHBG. The latter effect has also been observed in men suffering from the
metabolic syndrome [41]. Also a study by Macut et al. suggested that alterations of a
cross-talk between glucocorticoid signaling and metabolic parameters, is related to
PCOS pathophysiology [42].
Figure 3 Influence of dexamethasone and inflammation on IR genes that have a high score with
dexamethasone (> 25) and a low score with inflammation (<25). The direct score of these genes with
dexamethasone and inflammation are shown in grey. The literature neighbor score for these genes, by also
including the relations of dexamethasone and inflammation with genes to which the gene is connected in
the network, are shown in black. The grey arrows indicate the migration of the gene from a direct score to
a literature neighbor score.
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Additional topological analysis of the sub-network using cytohubba [43] revealed that
IGF1R, HSD11B2, IGF2 and SHBG have a high betweenness centrality, i.e. they have
many shortest paths going through them, analogous to major bridges and tunnels on a
high map. Studies show that such a bottle necks play important roles in biological net-
works [44,45].
CYP19A1 encodes for an aromatase which is responsible for the aromatization of
androgens into estrogens, thus influencing the androgen to estrogen balance. Several
studies showed that an imbalance between androgen and estrogen balance because of
aromatase deficiency resulted in the development of symptoms related to the metabolic
syndrome [46-49]. The fact that dexamethasone can regulate aromatase activity
[50-52], suggests a role of aromatase in GC induced IR.
CYP17A1 is a key regulator of androgen synthesis and catalyzes the reactions in
which pregnenolone and progesterone are converted into their 17-alpha-hydroxylated
products and subsequently into Dehydroepiandrosterone (DHEA). A decline in DHEA
and also its sulfated ester (DHEA-S) has been suggested to be causally linked to insulin
resistance and obesity [53-56]. The possible inhibitory effects of dexamethasone on
Cyp17a1 [57,58] suggests a role in GC induced IR by this gene.
CYP21A2 is a cytochrome P450 enzyme coding for the 21-hydroxylase that is
involved in the biosynthesis of the steroid hormones aldosterone and cortisol. A defect
Figure 4 Steroid synthesis. Enzymes indicated with a red box have been found in our analysis. CYP17A1
encodes for an enzyme which has both a 17α-hydroxylase and a 17,20 lyase function. CYP21A2 encodes for
a steroid 21-hydroxylase and CYP19A1 encodes for an aromatase. Figure derived from the image
Steroidogenesis.png in Wikipedia, by David Richfield and Mikael Häggström, licensed under Creative
Commons CC BY-SA 3.0 and GFDL.
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in this gene leads to Congenital adrenal hyperplasia (CAH) in which there is a disba-
lance in cortisol and aldosterone secretion. CAH patients are characterized by insulin
resistance, lower insulin sensitivity and hyperinsulinemia [43,59-61]. Some studies indi-
cate that the development of IR is because of GC treatment in this patient group
[62-64]. Whether these patients develop IR because of CAH and deficiency of 21-hydroxy-
lase, or because of the fact that they are often treated with synthetic GCs need to be
elucidated.
Genes involved in osteoporosis
Another side effect of GC treatment is the development of glucocorticoid induced osteopor-
osis (GIOP) [65]. GIOP is characterized by reduced bone mineral density (BMD), decreased
bone mass and disturbance of the bone matrix, leading to increased susceptibility to frac-
tures. We applied CoPubGene to deduce important genes involved in GIOP by analyzing
top scoring genes with OP (in total 131 genes associated with OP were found, see Add-
itional file 2: Table S5; the network of these top scoring genes with relations to dexametha-
sone and inflammation is shown in Additional file 6: Figure S3. The majority of the genes
are involved in bone remodeling and resorption (TNFRSF11A,TNFRSF11B,TNFSF11, SP7 ,
CTSK), in bone mineralization (PTH, Klotho, VDR, Calca, BGLAP) or are part of the wnt
signaling pathway that is involved in the regulation of bone formation (SOST, DKK1, LRP5,
LRP6) [66]. Among these genes are known biomarkers of GIOP such as osteoprotegerin
(encoded by TNFRSF11B) and the ligand RANK-L (encoded by TNFS11) [67]. Here we also
searched for genes with a low score with inflammation. Several of these genes in the set,
such as BGLAP, COL1A1 and SP7 are affected by GCs [68-72], have low associations with
inflammation and therefore are interesting biomarker candidates for GIOP.
Discussion
In the work presented here we used Medline abstracts to study mechanisms and genes
involved in glucocorticoid induced insulin resistance. We created CoPubGene, a num-
ber of web service operations that can be used to retrieve relevant gene-disease, gene-
drug and gene-gene associations out of Medline abstracts, using the CoPub technology.
The clustering of disease terms based on their associations with genes in Medline
abstracts showed that CoPubGene is able to generate a list of specific IR genes that can
be used for further analysis, and that this method also can be used to generate a variety
of other gene disease associations. We used this clustering to evaluate the quality of
disease related gene lists, generated using a text mining approach, because to our
knowledge there is no real gold standard data set that covers a sufficient range of gene-
disease associations that can be used. Databases such as OMIM and the KEGG disease
database [73] only cover a sub range of diseases which makes these datasets difficult to
use in this type of evaluation.
Next, we studied the IR genes in their functional context, by including genes with
which they co-occur in Medline abstracts. In this gene network we focused on genes
that are strongly linked to dexamethasone and less strongly to inflammation. These
genes are thought to be more exclusively related to GC induced IR and therefore might
be interesting markers for this effect.
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However, all of them are to a certain extent related to inflammation, either directly
or indirectly by their neighbors, which suggests that these genes cannot be used as an
exclusive marker for GC induced IR. This might have consequences for the search of
dissociating compounds, i.e. compounds which only have the immune suppressive
properties and not the unwanted side effects. Instead the search should focus on com-
pounds that show a reduced effect on the expression of these IR genes.
The majority of the IR genes that have a low literature neighbor score for inflamma-
tion (< 25) and a high score for dexamethasone (literature neighbor score > 25) code
for enzymes and hormones directly involved in important metabolic processes, such as
glycolysis, gluconeogenesis, glucose uptake and lipid metabolism. All these processes
are tightly regulated by insulin. This suggests that at a first instance, the search for
mechanisms of GC induced IR should be focused on these processes.
Additionally, we also identified a sub network of genes involved in sex steroid synthe-
sis that to our knowledge, not have been recognized yet as mediators of GC induced
side effects. Key enzymes involved in steroid synthesis, i.e. CYP17A1, CYP21A2 and
CYP19A1 keep the balance between several steroids, and an impairment of this balance
could possibly result in metabolic disturbances such as IR. Additional topological ana-
lyses could further prioritize this sub-network for follow-up studies to determine the
influence of GCs on sex steroid synthesis and the relation to IR. In such a study one
could look at the influence of GCs on the balance between the steroids in combination
with their influence on insulin stimulated glucose uptake in glucose sensitive tissues
such as adipose and muscle tissue.
Conclusions
Using CoPubGene we are able to construct an informative literature network of IR
related genes by only using information from Medline abstracts. Our approach revealed
genes, that on a first glance were not considered to be involved in GC induced IR and
thus gave new insights that might lead to a better understanding of the mechanisms be-
hind GC induced IR.
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